Come along to hear from Florey dementia researchers on how they are harnessing knowledge of the brain to better diagnose this condition and improve the level of dementia care, treatment and overall health outcomes, bringing hope to many.This event is free and will be available in-person (at the Kenneth Myer Building) and online (via Zoom) - head to Get Tickets to make your selection.
ABOUT THE EVENT
Unfortunately most of us know of someone who has been diagnosed with one of the many dementias that can occur.
The good news is that the diagnosis and treatment of dementia is rapidly changing, and The Florey’s brain research has been at the forefront of these developments.
Disease-modifying drugs is an exciting new area for dementia treatment. Up until now, we’ve only been able to improve the symptoms such as memory and cognition. But while new drugs coming onto the market are encouraging, they are not for everyone and there is plenty more being done to potentially modify and adapt effective treatment drugs.
ABOUT THE FLOREY
The Florey Institute of Neuroscience and Mental Health is the largest brain research centre in the Southern Hemisphere. Across three different campuses in Parkville, North Melbourne and Heidelberg, The Florey’s mission is to make dementia preventable and treatable. Our medical researchers work to develop life-changing discoveries in this field.
This panel discussion will showcase The Florey’s world-class brain research in developments for dementia diagnosis and treatment.
OUR PANEL:
Professor Scott Ayton, Dementia Mission Lead
Dr Rebecca Nisbet, Head of the Antibody Therapeutics Group
About the event
There will be a Q&A session followed by morning tea.
This event will also be available by Zoom.
Event Venue
The Florey Institute of Neuroscience and Mental Health, Kenneth Myer Building, Cnr Genetics Lane and Royal Pde,Melbourne,VIC,Australia
Tickets